Filters

Oryza sativa subsp. japonica ATP-citrate synthase alpha chain protein 3 (ACLA-3)

Oryza sativa subsp. japonica ATP-citrate synthase alpha chain protein 3 (ACLA-3) size: 100ug 2188

Supplier MBS RECOMBINANT PROTEINS
Price 2188
Size 100ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name japonica ATP-citrate synthase alpha chain protein 3 (ACLA-3), Recombinant Oryza sativa subsp
Alternative names ATP-citrate lyase A-3, ATP-citrate synthase alpha chain protein 3, Citrate cleavage enzyme A-3, Os12g0566300, hypothetical protein, Os12g0566300
Gene nameACLA-3
Other gene names ACLA-3, ATP-citrate synthase A-3, Os12g0566300
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, ATP-citrate synthase alpha chain protein 3 (ACLA-3) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene target japonica ATP-citrate synthase alpha chain protein 3 (ACLA-3), Oryza sativa subsp
Short name japonica ATP-citrate synthase alpha chain protein 3 (ACLA-3), Oryza sativa subsp
Alternative name japonica adenosine triphosphate-citrate synthase a epitope protein 3 (ACLA-3), Oryza sativa subsp

Similar products

Subscribe to our Newsletter